Latest News & Updates
Breaking News
2 hours ago
Vaibhavi M.
Other trending news you may like to read
Japan Grants First Global Approval To Chugai’s Lunsumio–Polivy Combination For Relapsed Large B-Cell Lymphoma
Japan Grants First Global Approval To Chugai’s Lunsumio–Polivy Combination For Relapsed Large B-Cell Lymphoma
Vaibhavi M.
Theriva Secures FDA Agreement On Phase 3 Trial Design For VCN-01 In Metastatic Pancreatic Cancer
Theriva gains FDA agreement on Phase 3 trial design for VCN-01 with chemotherapy in metastatic pancreatic ductal adenocarcinoma, advancing toward potential biologics license filing.
Vaibhavi M.
Oryzon Secures U.S. Patent for Iadademstat–Venetoclax Combination Therapies In Acute Myeloid Leukaemia, Strengthening Global Oncology IP
Oryzon secures US patent for iadademstat combinations with venetoclax for acute myeloid leukaemia, extending IP protection to 2039 and supporting ongoing clinical trials.
Vaibhavi M.
Tarsus Secures $15 Million Milestone As China Approves TP-03 Eye Therapy Through Grand Pharma Partnership
Tarsus secures $15M milestone after China approves TP-03 (lotilaner ophthalmic solution) for Demodex blepharitis via Grand Pharma, enabling commercialisation across Greater China.
Vaibhavi M.
